Genetic Correction of Sickle Cell Anemia and β-Thalassemia: Progress and New Perspective
Gene therapy for β-globinopathies, particularly β-thalassemia and sickle cell anemia, holds promise for the future as a definitive corrective approach for these common and debilitating disorders. Correction of the β-globinopathies using lentivirus vectors carrying the β- or γ-globin genes and elemen...
Saved in:
Main Authors: | Ajay Perumbeti, Punam Malik |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2010-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/tsw.2010.67 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of Asymptomatic Brain Lesions Between Thalassemia Major and Sickle Cell Anemia Patients
by: Derya Yavuz Demiray, et al.
Published: (2025-01-01) -
Sickle Cell Beta-Plus Thalassemia with Subcapsular Hematoma of the Spleen
by: Suyash Dahal, et al.
Published: (2017-01-01) -
β-Thalassemia: New Therapeutic Modalities, Genetics, Complications, and Quality of Life
by: Mehran Karimi, et al.
Published: (2012-01-01) -
HbS-Sicilian (δβ)0-Thalassemia: A Rare Variant of Sickle Cell
by: Grace Onimoe, et al.
Published: (2017-01-01) -
Red Blood Cell Alloimmunization and Autoimmunization in Blood Transfusion-Dependent Sickle Cell Disease and β-Thalassemia Patients in Al-Ahsa Region, Saudi Arabia
by: Fahd A. Kuriri, et al.
Published: (2023-01-01)